Results 191 to 200 of about 6,278 (225)

Insights From Cardiovascular Outcome Trials with Novel Antidiabetes Agents: What Have We Learned? An Industry Perspective

Current Diabetes Reports, 2015
Hirshberg Boaz
exaly  

Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study

Diabetes Care, 2020
Lars Vedel Kessing, Claus Thorn Ekstrøm, Filip K Knop   +2 more
exaly  

Analyzing Antidiabetes Drug Prescriptions With World Health Organization Anatomical Therapeutic Chemical/Defined Daily Dose Index to Assess Drug Utilization Pattern in Elderly Population of Rural Eastern India

Indian Journal of Clinical Medicine, 2017
Sandeep Lahiry, Avijit Kundu, AYAN Mukherjee   +2 more
exaly  

Antidiabetics

2018
openaire   +1 more source

Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial

Diabetes, Obesity and Metabolism, 2012
P Raskin, Simon Heller, Najaf Amin
exaly  

ORAL ANTIDIABETIC AGENTS

Medical Journal of Australia, 1970
openaire   +2 more sources

Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial

Lancet, The, 2013
Holger Huisman, Maximilian Von Eynatten, Sanjay R Patel   +2 more
exaly  

Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

Diabetes Care, 2018
Olga Montvida, Jonathan E Shaw, John J Atherton   +2 more
exaly  

Association Between Bariatric Surgery and Rates of Continuation, Discontinuation, or Initiation of Antidiabetes Treatment 6 Years Later

JAMA Surgery, 2018
Jeremie Thereaux, Sébastien Czernichow, Simon Msika   +2 more
exaly  

ANTIDIABETIC DRUGS AND ATHEROGENESIS

The Lancet, 1970
openaire   +2 more sources